Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (157)

Latest Posts

About This Stock More About This Stock
Good Medicine At Bargain Prices
Article By: Bill Smead
Wednesday, June 30, 2021 9:10 PM EDT
The pandemic has provoked a rethinking of pharma-biotech in our society.
In this article: MRK, PFE, AMGN Also: KO, LLY, AAPL
Read
Which Is A Better Investment? Amgen Vs Bristol-Myers Squibb… The Winner May Surprise You
Video By: Jason Fieber
Wednesday, June 23, 2021 11:04 AM EDT
Both companies have the same yield, at right about 2.9%. They've also both been increasing their dividends for almost the same exact length of time - 12 years for Bristol-Myers Squibb versus 11 years for Amgen.
In this video: BMY, AMGN
Watch
FV This Stock Should Be On Your Radar: It’s Selling At A 10% Discount And Rated A “Buy”
Video By: Jason Fieber
Monday, June 21, 2021 9:55 AM EDT
There’s a common misperception among investors. This misperception is that you have to look far and wide for great long-term investment ideas. It’s as if blue-chip companies that are household names can’t continue to do well over the long run.
In this video: AMGN
Watch
3 Promising Oncology Stocks To Consider Adding To Your Portfolio
Article By: StockNews
Monday, June 14, 2021 12:31 AM EDT
With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio.
In this article: AZN, INCY, AMGN Also: SPY, CNCR
Read
4 Biotech Stocks To Buy For The Q2 2021
Article By: StockNews
Monday, April 5, 2021 6:45 AM EDT
The global biotechnology market is expected to expand at a CAGR of 15.8% between 2021 – 2028.
In this article: JAZZ, AMGN, GILD, QGEN
Read

Latest Tweets for $AMGN

No tweets yet!

$AMGN

July 2017 Stock Considerations
Dick Kaplan 7/3/2017 3:14:44 AM

I read that #Repatha sales for this quarter are down significantly so be careful with $AMGN.

1 to 1 of 1 comments